Comorbidities between nose and skin allergy

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 5, 2011, Pages 457-463

  Olze, Heidi ^a   Zuberbier, Torsten ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

allergic rhinitis; atopic dermatitis; chronic rhinosinositis; comorbidities; urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CALGRANULIN A; CALGRANULIN B; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; IMMUNOGLOBULIN E; INTERLEUKIN 5; OMALIZUMAB; PSORIASIN; T LYMPHOCYTE RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN;

ALLERGIC ASTHMA; ALLERGIC REACTION; ALLERGIC RHINITIS; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CHRONIC RHINOSINUSITIS; CHRONIC URTICARIA; COMORBIDITY; CONTACT URTICARIA; DESENSITIZATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EAR NOSE THROAT DISEASE; EOSINOPHIL; FRONTAL SINUS; HUMAN; MAST CELL; NONHUMAN; NOSE POLYP; PATCH TEST; PATHOGENESIS; PRICK TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; RHINOSINUSITIS; SINUSITIS; SKIN TEST; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; URTICARIA;

COMORBIDITY; DERMATITIS, ATOPIC; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; NOSE; RESPIRATORY HYPERSENSITIVITY; RHINITIS; SINUSITIS; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; URTICARIA;

EID: 80052464291     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32834a9764     Document Type: Review

References (81)

1. Skin immune system: defensins and cathelicidins. 2005. Amsterdam: Kisich KO, Leung DYM. 2005
2. Williams H, Stewart A, von Mutius E, et al. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121:947-954
3. Malm-Erjefält M, Greiff L, Ankerst J, et al. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation. Clin Exp Allergy 2005; 35:1334-1340
4. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update [in collaboration with the World Health Organization, GA(2)LEN and AllerGen]. Allergy 2008; (Suppl 86):8-160 (Pubitemid 351357811)
5. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225-1232
6. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368:733-743 (Pubitemid 44279052)
7. Bjorksten B, Clayton T, Ellwood P, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19:110-124 (Pubitemid 351197288)
8. Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62:758-766
9. Ohshima Y, Yamada A, Hiraoka M, et al. Early sensitization to house dust mite is a major risk factor for subsequent development of bronchial asthma in Japanese infants with atopic dermatitis: results of a 4-year follow-up study. Ann Allergy Asthma Immunol 2002; 89:265-270 (Pubitemid 36188025)
10. Barnetson RS, Rogers M. Childhood atopic eczema. Br Med J 2002; 324:1376-1379 (Pubitemid 34628013)
11. Kulig M, Bergmann R, Klettke U, et al. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999; 103:1173-1179 (Pubitemid 29343086)
12. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis: a prospective follow-up to years of age. Allergy 2000; 55:240-245 (Pubitemid 30146119)
13. Kapoor R, Menon C, Hoffstad O, et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58:68-73 (Pubitemid 350298135)
14. Ricci G, Patrizi A, Baldi E, et al. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J Am Acad Dermatol 2006; 55:765-771 (Pubitemid 44556833)
15. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007; 120:565-569 (Pubitemid 47334839)
16. Simpson CR, Newton J, Hippisley-Cox J, Sheikh A. Incidence and prevalence of multiple allergic disorders recorded in a national primary care database. J R Soc Med 2008; 101:558-563
17. Strachan DP, Sheikh A. A life course approach to respiratory and allergic diseases. In: Kuh D, Ben-Shlomo Y, editors. A life course approach to chronic disease epidemiology. 2nd ed. Oxford: Oxford University Press; 2004
18. Punekar YS, Sheikh A. Establishing the sequential progression of multiple allergic diagnoses in a UK birth cohort using the General Practice Research Database. Clin Exp Allergy 2009; 39:1889-1895
19. Novembre E, Cianferoni A, Lombardi E, et al. A natural history of 'intrinsic' atopic dermatitis. Allergy 2001; 56:452-453 (Pubitemid 32452694)
20. Wuthrich B, Schmid-Grendelmeier P. Natural course of AEDS. Allergy 2002; 57:267-268 (Pubitemid 34250768)
21. Nowacki Z, Neuberg J, Strzalka K, et al. Is prediction of the allergic march possible on the basis of nasal cytology? Pneumonol Alergol Pol 2010; 78:263-270
22. Fuiano N, Incorvaia C, Prodam F, et al. Relationship between the atopy patch test and clinical expression of the disease in children with atopic eczema/ dermatitis syndrome and respiratory symptoms. Ann Allergy Asthma Immunol 2008; 101:174-178
23. Hon KL, Wong KY, Leung TF, et al. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 2008; 9:45-50
24. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112:118-127
25. Akei HS, Brandt EB, Mishra A, et al. Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J Allergy Clin Immunol 2006; 118:62-69 (Pubitemid 43946489)
26. Lee GR, Flavell RA. Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma. Int Immunol 2004; 16:1155-1160 (Pubitemid 39136732)
27. Spergel JM, Mizoguchi E, Brewer JP, et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-1622 (Pubitemid 28198490)
28. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90:525-530
29. Nomura I, Tanaka K, Tomita H, et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999; 104:441-446 (Pubitemid 29420444)
30. Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258 (Pubitemid 46294541)
31. Bunikowski R, Mielke ME, Skarabis H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105:814-819 (Pubitemid 30226458)
32. Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax 2000; 55 (Suppl 2):20-21
33. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyposis. Executive summary. Allergy 2005; 60:583-601 (Pubitemid 40562464)
34. Van Bruaene N, Perez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121:1435-1441
35. Huvenne W, Van Bruaene N, Zhang N, et al. Chronic rhinosinusitis with and without nasal polyps: what is the difference? Curr Allergy Asthma Rep 2009; 9:213-220
36. van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-1289 (Pubitemid 44465587)
37. Bachert C, Van Bruaene N, Toskala E, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis: a GALEN study. Allergy 2009; 64:520-533
38. Olze H, Förster U, Zuberbier T, et al. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology 2006; 44:145-150 (Pubitemid 43862942)
39. Simon HU, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997; 158:3902-3908 (Pubitemid 127488750)
40. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004; 59:561-570 (Pubitemid 38748052)
41. Yamamoto N, Sugiura H, Tanaka K, Uehara M. Heterogeneity of interleukin genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels. J Dermatol Sci 2003; 33:121-126 (Pubitemid 37321371)
42. Nonaka M, Pawankar R, A. Fukumoto A, et al. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Clin Exp Allergy 2004; 34:804-811 (Pubitemid 38736798)
43. Olze H, Förster U, Krenn, et al. Increased CCR3- and eotaxin mRNA expression in eosinophilic nasal polyps. Allergologie 2006; 29:125-134
44. Chandra RK, Lin D, Tan B, et al. Chronic rhinosinusitis in the setting of other chronic inflammatory diseases. Am J Otolaryngol 2010. doi: 10.1016/j.amjoto. 2010.07.013
45. Bachert C, Zhang N, Patou J, et al. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 2008; 8:34-38
46. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114:981-983 (Pubitemid 39330280)
47. Tripathi A, Kern R, Conley DB, et al. Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 2005; 19:327-333 (Pubitemid 41341771)
48. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:1061-1068
49. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4:978-988 (Pubitemid 39620072)
50. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007; 28:248-251 (Pubitemid 46810353)
51. Van Bruaene N, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:253-259
52. Richer SL, Truong-Tran AQ, Conley DB, et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol 2008; 22:228-234 (Pubitemid 351846801)
53. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:37-42
54. Plager DA, Kahl JC, Asmann YW, et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 2010; 5:e11450
55. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27:451-483
56. Hume DA. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol 2008; 1:432-441
57. Johnson-Huang LM, McNutt NS, Krueger JG, et al. Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol 2009; 29:247-256
58. Gros E, Bussmann C, Bieber T, et al. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 2009; 124:753-760
59. Elishmereni M, Alenius HT, Bradding P, et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011; 66:376-385
60. Sheinkopf LE, Rafi AW, Do LT, et al. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study. Allergy Asthma Proc 2008; 29:530-537
61. Penn R, Mikula S. The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study. Am J Rhinol 2007; 21:428-432 (Pubitemid 47360029)
62. Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE for the treatment of allergic rhinitis: and eventually nasal polyps? Int Arch Allergy Immunol 2009; 148:87-98
63. Amerio P, Frezzolini A, Feliciani C, et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy 2003; 2:81-94
64. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426
65. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64:1427-1443
66. Zuberbier T, Ifflander J, Semmler C, Henz BM. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996; 76:295-297 (Pubitemid 26247000)
67. Zuberbier T, Edenharter G, Worm M, et al. Prevalence of adverse reactions to food in Germany: a population study. Allergy 2004; 59:338-345 (Pubitemid 38339853)
68. Zuberbier T, Balke M, Worm M, et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35:869-873
69. Urticaria: clinical, diagnostic and therapeutic aspects 1998. Berlin: Henz BM, Zuberbier T, Grabbe J, Monroe E; 1998
70. Rask-Andersen A, Boman J, Grangsjo A, et al. Asthma, skin symptoms, and allergy in a condom factory. Allergy 2000; 55:836-841 (Pubitemid 30643908)
71. Zuberbier T, Althaus C, Chantraine-Hess, Czarnetzki BM. Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994; 31:978-981 (Pubitemid 24365037)
72. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5:10
73. Araujo E, Palombini BC, Cantarelli V, et al. Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol 2003; 17:9-15 (Pubitemid 36395381)
74. Plouin-Gaudon I, Clement S, Huggler E, et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 2006; 44:249-254 (Pubitemid 46029235)
75. Wedi B, Raab U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4:387-396 (Pubitemid 39274080)
76. Ertam I, Biyikli SE, Yazkan FA, et al. The frequency of nasal carriage in chronic urticaria patients. J Eur Acad Dermatol Venereol 2007; 21:777-780 (Pubitemid 46939050)
77. Buss YA, Garrelfs UC, Sticherling M. Chronic urticaria: which clinical parameters are pathogenetically relevant? A retrospective investigation of patients. J Dtsch Dermatol Ges 2007; 5:22-29 (Pubitemid 46086067)
78. Jirapongsananuruk O, Sangacharoenkit P, Pongpreuksa S, et al. Is silent sinusitis a cause of chronic urticaria in children? Asian Pac J Allergy Immunol 2009; 27:103-106
79. Hirschberg. Mitteilung ü ber einen Fall von Nebenwirkung des Aspirin. DMW Dtsch Med Wochenschr 1902; 23:416-417
80. Widal MF, Abramin P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922; 30:189-193
81. Nizankowska-Mogilnicka, Bochenek E, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:1111-1118 (Pubitemid 47374015)